NCT05325528 2023-02-01
Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases
Zhejiang University
Phase 2/3 Unknown
Zhejiang University
Ruijin Hospital
Blokhin's Russian Cancer Research Center
Third Military Medical University
University of Birmingham
Sichuan Provincial People's Hospital
Fudan University
Sun Yat-sen University
Sixth Affiliated Hospital, Sun Yat-sen University
Medical University of Lublin
Fudan University
National Cancer Institute (NCI)